Nu Skin Enterprises, Inc. (NYSE:NUS – Get Free Report) saw a significant decline in short interest during the month of August. As of August 31st, there was short interest totalling 1,320,000 shares, a decline of 19.5% from the August 15th total of 1,640,000 shares. Based on an average trading volume of 818,700 shares, the short-interest ratio is presently 1.6 days. Approximately 2.7% of the shares of the stock are short sold.
Insiders Place Their Bets
In other Nu Skin Enterprises news, Director Andrew D. Lipman sold 2,000 shares of Nu Skin Enterprises stock in a transaction dated Friday, August 25th. The shares were sold at an average price of $23.33, for a total transaction of $46,660.00. Following the completion of the transaction, the director now owns 56,625 shares in the company, valued at $1,321,061.25. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. In other news, Director Andrew D. Lipman sold 2,000 shares of the business’s stock in a transaction that occurred on Friday, August 25th. The shares were sold at an average price of $23.33, for a total value of $46,660.00. Following the completion of the transaction, the director now owns 56,625 shares of the company’s stock, valued at $1,321,061.25. The transaction was disclosed in a document filed with the SEC, which is accessible through this link. Also, Director Laura Nathanson sold 6,068 shares of the business’s stock in a transaction that occurred on Monday, August 21st. The shares were sold at an average price of $24.12, for a total transaction of $146,360.16. Following the completion of the transaction, the director now directly owns 10,300 shares of the company’s stock, valued at approximately $248,436. The disclosure for this sale can be found here. Over the last quarter, insiders sold 13,340 shares of company stock worth $348,503. Insiders own 2.00% of the company’s stock.
Institutional Trading of Nu Skin Enterprises
Several hedge funds have recently bought and sold shares of NUS. State Street Corp increased its stake in Nu Skin Enterprises by 317.6% during the 1st quarter. State Street Corp now owns 6,520,579 shares of the company’s stock valued at $312,205,000 after buying an additional 4,959,089 shares during the period. Millennium Management LLC increased its stake in Nu Skin Enterprises by 5,827.8% during the 4th quarter. Millennium Management LLC now owns 975,176 shares of the company’s stock valued at $41,113,000 after buying an additional 958,725 shares during the period. Marshall Wace LLP acquired a new position in Nu Skin Enterprises during the 2nd quarter valued at about $21,804,000. Charles Schwab Investment Management Inc. grew its stake in shares of Nu Skin Enterprises by 87.7% in the 1st quarter. Charles Schwab Investment Management Inc. now owns 847,921 shares of the company’s stock worth $33,332,000 after purchasing an additional 396,238 shares during the last quarter. Finally, Norges Bank acquired a new position in shares of Nu Skin Enterprises in the 4th quarter worth approximately $12,917,000. 73.62% of the stock is currently owned by institutional investors.
Nu Skin Enterprises Stock Performance
Nu Skin Enterprises (NYSE:NUS – Get Free Report) last posted its quarterly earnings results on Tuesday, August 1st. The company reported $0.54 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.53 by $0.01. Nu Skin Enterprises had a net margin of 3.43% and a return on equity of 12.88%. The company had revenue of $500.26 million for the quarter, compared to the consensus estimate of $512.35 million. As a group, analysts expect that Nu Skin Enterprises will post 2.47 EPS for the current fiscal year.
Nu Skin Enterprises Announces Dividend
The company also recently disclosed a quarterly dividend, which was paid on Wednesday, September 6th. Investors of record on Friday, August 25th were given a $0.39 dividend. The ex-dividend date of this dividend was Thursday, August 24th. This represents a $1.56 annualized dividend and a yield of 6.64%. Nu Skin Enterprises’s dividend payout ratio is presently 110.64%.
Analysts Set New Price Targets
A number of equities research analysts recently issued reports on NUS shares. Stifel Nicolaus lowered their target price on shares of Nu Skin Enterprises from $43.00 to $35.00 and set a “hold” rating for the company in a report on Wednesday, August 2nd. StockNews.com started coverage on shares of Nu Skin Enterprises in a research note on Thursday, August 17th. They set a “hold” rating for the company. Finally, DA Davidson decreased their price objective on shares of Nu Skin Enterprises from $38.00 to $29.00 and set a “neutral” rating for the company in a research note on Thursday, August 3rd. Five investment analysts have rated the stock with a hold rating, According to MarketBeat.com, Nu Skin Enterprises currently has a consensus rating of “Hold” and an average price target of $36.00.
Nu Skin Enterprises Company Profile
Nu Skin Enterprises, Inc, together with its subsidiaries, develops and distributes various beauty and wellness products worldwide. It offers skin care devices, cosmetics, and other personal care products, including ageLOC LumiSpa and ageLOC LumiSpa iO, ageLOC Body Spa; and nutricentials skin care products.
- Five stocks we like better than Nu Skin Enterprises
- How to Invest in Casino Stocks
- 5 Reasons Mullen Automotive is About to Turn a Corner
- What Are Dividend Champions? How to Invest in the Champions
- Qualcomm and Apple Forge Ahead with New Modem Partnership
- Manufacturing Stocks Investing
- Can These 3 Healthcare Dividend Stocks Deliver Income Growth?
Receive News & Ratings for Nu Skin Enterprises Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nu Skin Enterprises and related companies with MarketBeat.com's FREE daily email newsletter.